Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Oct 13, 2026

EWTX — Edgewise Therapeutics, Inc. Dilution Risk Tracker

Track EWTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EWTX — Get alerts when the score changes →

As of October 13, 2026, Edgewise Therapeutics, Inc. (EWTX) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Edgewise Therapeutics, Inc. has a market capitalization of $4.18B, 108.60M shares outstanding, 218 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
26
💰 Cash Runway
65
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (7mo)
🔔 Track EWTX — Get forecast alerts →

Market Data

Market Cap$4.18B
Shares Outstanding108.60M
Float67.12M
Cash$72.32M
Debt$66.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore35/100DilutionWatch score record
Shares Outstanding108.60MVerified float table or market cache
Public Float67.12MVerified float table or market cache
Market Cap$4.18BMarket data cache
Cash Runway6.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 14.5% shares (2026Q1 vs prior)
218 institutional holders · 141.38M shares
#1 ORBIMED ADVISORS LLC 15.52M shares
#2 JANUS HENDERSON GROUP PLC 11.83M shares
#3 RA CAPITAL MANAGEMENT, L.P. 10.43M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest11.22M
Days to Cover5.6
% of Float16.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2023-02-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual EWTX Dilution Snapshot

Edgewise Therapeutics, Inc. (EWTX) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

EWTX's DilutionScore is currently 35/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 50/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202635/100MEDIUM53 days
Jul 16 – Aug 21, 202650/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

EWTX shares outstanding have increased 1.6% from 105.87M (Mar 2026) to 107.59M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 19, 2026107.59M67.12M▼ 1.21%
May 16, 2026107.59M67.94M▲ 0.03%
May 09, 2026107.59M67.92M▲ 0.31%
May 04, 2026107.53M67.71M▲ 0.14%
Apr 04, 2026107.27M67.62M▲ 0.02%
Mar 04, 2026105.87M67.60M▲ 9.64%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track EWTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment EWTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking EWTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for EWTX
EWTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.